Company: TEM
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000950170-25-025603
Chunk: 515

Company: Tempus AI, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 1B
Chunk 515
---
 by compounding interest on our Amended Note and additional debt entered into under our Term Loan Facility in April and October 2023. 

Other Income, net 

    Year Ended December 31,

    2024

    2023

    $ Change

    % Change

    (in thousands, except percentages)

    Other income, net
     
    $
    32,336

    $
    21,822

    $
    10,514

    48
    %

The change in Other income, net for the year ended December 31, 2024, compared to the same period in 2023, was primarily driven by a $50.4 million increase in expense related to the change in fair value of our warrant liability and a $2.3 million expense for the G-4 Special Payment (as defined in Note 10 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K). The increase in expense was offset by $39.1 million in income related to termination of the warrant with AstraZeneca, $14.2 increase in income due to the change in fair value of our warrant asset, and $8.0 in income from the IP License Agreement with SB Tempus, and $2.3 million in income related to gains on marketable equity securities.

128

Provision for income taxes 

    Year Ended December 31,

    2024

    2023

    $ Change

    % Change

    (in thousands, except percentages)

    Provision for income taxes
     
    $
    (266
    )
     
    $
    (288
    )
     
    $
    22

    -8
    %

The decrease in provision for income taxes for the year ended December 31, 2024, compared to the same period in 2023, was not material. 

Losses from Equity Method Investments 

    Year Ended December 31,

    2024

    2023

    $ Change

    % Change

    (in thousands, except percentages)

    Losses from equity method investments
     
    $
    (4,228
    )
     
    $
    (301
    )
     
    $
    (3,927
    )

    1305
    %

The increase in losses from equity method investments for the year ended December 31, 2024, compared to the same period in 2023, was due to